Pelvic Inflammatory Disease and Fertility: What Every Woman Should Know

Pelvic inflammatory disease — PID — is an ascending infection of the female reproductive tract, spreading from the vagina and cervix upward into the uterus, fallopian tubes, ovaries, and surrounding peritoneum. It is one of the most common serious gynaecological infections in reproductive-age women and one of the most important preventable causes of tubal infertility, ectopic pregnancy, and chronic pelvic pain in India.

The challenge with PID is that it is often clinically subtle — many cases are mild or asymptomatic, and treatment is delayed or inadequate because the diagnosis is not considered. The consequences of this delay — tubal scarring, hydrosalpinx, peritubal adhesions — may not become apparent until years later, when a woman tries to conceive and discovers that her tubes are permanently damaged.

What Causes PID?

PID is caused by microorganisms ascending from the lower genital tract. The most important pathogens are:

• Neisseria gonorrhoeae (gonorrhoea): A sexually transmitted bacterium that is a particularly aggressive cause of PID — rapid ascending infection, severe tubal inflammation.
• Chlamydia trachomatis: The most common sexually transmitted infection globally and in India — often asymptomatic in both partners. Chlamydial PID tends to be more insidious and more likely to be "silent," leading to delayed diagnosis and more extensive tubal damage from prolonged, untreated infection.
• Bacterial vaginosis-associated organisms: Anaerobes, Gardnerella vaginalis, and other endogenous vaginal flora that ascend — particularly in the context of disrupted vaginal flora — can cause polymicrobial PID.
• Other STIs: Mycoplasma genitalium is increasingly recognised as a PID pathogen. Bacterial co-infection is common.

Who Is at Risk?

PID occurs in sexually active women of reproductive age. Specific risk factors:

• Younger age: Women under 25 have higher cervical ectopy (columnar epithelium at the cervical os), making ascending infection more likely.
• Multiple sexual partners or a new partner in the past 3 months
• Previous PID: The most significant risk factor for recurrent PID
• Recent intrauterine procedure: IUD insertion, hysteroscopy, endometrial biopsy, or other procedure that disrupts the cervical barrier
• Bacterial vaginosis: Disrupted vaginal microbiome facilitates ascent of pathogenic organisms

Symptoms of PID

PID presents along a clinical spectrum from asymptomatic to severely ill:

Mild to Moderate PID

• Lower abdominal pain — bilateral, often dull or cramping
• Abnormal vaginal discharge — may be purulent, malodorous
• Intermenstrual bleeding or post-coital bleeding
• Dyspareunia (pain during intercourse)
• Cervical motion tenderness on pelvic examination — the most specific clinical sign of PID
• Adnexal tenderness on bimanual examination

Severe PID (Tubo-ovarian Abscess, Peritonitis)

• High fever, rigors
• Severe lower abdominal pain
• Signs of peritonitis — guarding, rebound tenderness
• Palpable pelvic mass (tubo-ovarian abscess)
• Nausea, vomiting

Severe PID with tubo-ovarian abscess (TOA) requires hospitalisation and IV antibiotics — and sometimes surgical drainage if the abscess does not respond to medical management.

Diagnosing PID

No single test definitively diagnoses PID. The clinical diagnosis is made on a combination of:

• Clinical features: Lower abdominal pain, cervical motion tenderness, and adnexal tenderness on pelvic examination (CDC minimum criteria)
• Elevated inflammatory markers: CRP, ESR, elevated white cell count
• Endocervical swabs: For gonorrhoea and chlamydia — positive results confirm the diagnosis and guide antibiotic choice, but negative results do not exclude PID
• Pelvic ultrasound: Can show free fluid, thickened fluid-filled tubes (pyosalpinx), or tubo-ovarian abscess
• Laparoscopy: The gold standard — direct visualisation of pelvic inflammation, tubal erythema, exudate. Used when diagnosis is uncertain or when conservative treatment is failing.

Because the consequences of undertreated PID are severe, the CDC and most guidelines recommend a low threshold for empirical treatment — if PID is clinically suspected, treat, rather than wait for laboratory confirmation.

Treatment of PID

Broad-spectrum antibiotics covering gonorrhoea, chlamydia, and anaerobes are the cornerstone of treatment. Outpatient regimens (for mild to moderate PID without TOA):

• Ceftriaxone 500 mg IM single dose + doxycycline 100 mg twice daily for 14 days + metronidazole 400 mg twice daily for 14 days — one of the most widely recommended regimens.
• Azithromycin-based alternatives for chlamydia coverage; quinolone-based if gonorrhoea resistance patterns in the local area permit.

Inpatient IV antibiotic therapy for: TOA, severe symptoms, failure to respond to outpatient treatment, immunocompromised patients, pregnancy.

Partner treatment: All sexual partners in the preceding 60 days should be offered testing and treatment for gonorrhoea and chlamydia — even if asymptomatic.

PID and Fertility: The Long-Term Consequences

Even a single episode of PID — adequately treated — causes tubal damage in approximately 10 to 15% of women. The cumulative risk after multiple episodes or after delayed/inadequate treatment is much higher:

• After 1 episode of PID: approximately 10 to 15% risk of tubal factor infertility
• After 2 episodes: approximately 25 to 30%
• After 3 or more episodes: approximately 50 to 60%

The specific fertility consequences include bilateral or unilateral tubal blockage, peritubal adhesions preventing ovum capture, hydrosalpinx (fluid-filled blocked tube — toxic to embryos), and significantly elevated ectopic pregnancy risk.

Women with a history of PID who are trying to conceive should have their tubal status assessed — by HSG, HyCoSy, or laparoscopy — before attempting natural conception for more than 6 months, or before starting fertility treatment. A hydrosalpinx must be managed before IVF (see P2-5).

Frequently Asked Questions

Q1. I had PID years ago and didn't know. Could my infertility be related?

Yes — this is unfortunately common. Many cases of PID are mild or asymptomatic and never formally diagnosed. Women who have had any history of pelvic infection symptoms, STIs, or unexplained pelvic pain should have tubal assessment as part of infertility investigation. The key test is hysterosalpingography (HSG) or laparoscopy with chromopertubation.

Q2. Can PID be cured completely?

The infection itself can be cured with appropriate antibiotic treatment. The structural damage caused by the infection — tubal scarring, adhesions, hydrosalpinx — is not reversible with antibiotics. This is why prompt treatment is so critical: every day of untreated infection allows more scarring to develop. Treating PID within 3 days of symptom onset is associated with significantly better fertility outcomes than delayed treatment.

Q3. Is PID preventable?

To a significant degree. Using condoms consistently, regular STI screening for sexually active women (particularly chlamydia, which is frequently asymptomatic), prompt treatment of any STI in either partner, and treatment of bacterial vaginosis when detected all reduce PID risk. The availability of rapid point-of-care STI testing in India is improving; primary care providers should routinely offer STI screening to sexually active women under 25.

DISCLAIMER: This article is for educational purposes only and does not constitute medical advice. Consult Dr. Sunita Tandulwadkar or a qualified specialist for personalised guidance. Solo Clinic IVF & ObGyn, Pune.